CAS 1259305-29-7

Aripiprazole lauroxil

Description:

Aripiprazole lauroxil is an atypical antipsychotic medication primarily used for the treatment of schizophrenia and as an adjunct for major depressive disorder. It is a long-acting injectable formulation of aripiprazole, designed to provide sustained therapeutic effects with less frequent dosing compared to oral formulations. The substance is characterized by its prodrug nature, which means it is metabolized in the body to release the active form, aripiprazole. This compound exhibits a unique mechanism of action, functioning as a partial agonist at dopamine D2 receptors and serotonin 5-HT1A receptors, while acting as an antagonist at 5-HT2A receptors. This dual activity helps to stabilize mood and reduce psychotic symptoms. Aripiprazole lauroxil is typically administered via intramuscular injection, allowing for a gradual release into the bloodstream. Its pharmacokinetics, including absorption, distribution, metabolism, and excretion, are designed to optimize patient adherence and minimize fluctuations in drug levels, contributing to its efficacy in managing chronic psychiatric conditions.

Formula: C₃₆H₅₁Cl₂N₃O₄

InChI: InChI=1S/C36H51Cl2N3O4/c1-2-3-4-5-6-7-8-9-10-16-35(43)45-28-41-33-27-30(19-17-29(33)18-20-34(41)42)44-26-12-11-21-39-22-24-40(25-23-39)32-15-13-14-31(37)36(32)38/h13-15,17,19,27H,2-12,16,18,20-26,28H2,1H3

InChI key: InChIKey=DDINXHAORAAYAD-UHFFFAOYSA-N

SMILES: C(OC(CCCCCCCCCCC)=O)N1C=2C(=CC=C(OCCCCN3CCN(CC3)C4=C(Cl)C(Cl)=CC=C4)C2)CCC1=O

Aripiprazole Lauroxil

CAS: 1259305-29-7

Aripiprazole lauroxil, the N-acyloxymethyl prodrug form of aripiprazole, a long-acting injectable (LAI) antipsychotic.

Formula: C₃₆H₅₁Cl₂N₃O₄

Purity: 99.64%

Color and Shape: Solid

Molecular weight: 660.71

Ref: TM-T14319

Dodecanoic acid, [7-[4-[4-(2,3-dichlorophenyl)-1-piperazinyl]butoxy]-3,4-dihydro-2-oxo-1(2H)-quinolinyl]methyl ester

CAS: 1259305-29-7

Formula: C₃₆H₅₁Cl₂N₃O₄

Purity: 98%

Color and Shape: Solid

Molecular weight: 660.7138

Ref: IN-DA000OZ0

Aripiprazole Lauroxil

CAS: 1259305-29-7

Aripiprazole Lauroxil

Purity: ≥98%

Molecular weight: 660.71g/mol

Ref: 54-BUP13755

Aripiprazole lauroxil

Controlled Product

CAS: 1259305-29-7

Formula: C₃₆H₅₁N₃O₄Cl₂

Color and Shape: Neat

Molecular weight: 660.71

Ref: TR-A771028

Aripiprazole Lauroxil

CAS: 1259305-29-7

Formula: C₃₆H₅₁Cl₂N₃O₄

Molecular weight: 660.72

Ref: ST-EA-CP-A22060

Aripiprazole lauroxil

CAS: 1259305-29-7

Aripiprazole lauroxil is a long-acting injectable antipsychotic that belongs to the class of drugs known as atypical antipsychotics. Aripiprazole lauroxil has been shown to be effective in treating schizophrenia and other psychotic disorders, such as bipolar disorder. The drug was well tolerated in clinical trials and had no serious adverse effects. Aripiprazole lauroxil is administered by intramuscular injection once every six months and has a high efficacy rate with no significant side effects.

Formula: C₃₆H₅₁Cl₂N₃O₄

Purity: Min. 95%

Molecular weight: 660.71 g/mol

Ref: 3D-FA176243